Lifestyle for Brain Health — Time-Restricted Eating and Mindfulness
Official title: Lifestyle for the BRAin Health - Time Restricted Eating and Mindfulness
Run by St. Anne's University Hospital Brno, Czech Republic · NCT07042087 · Data updated 2026-11-12
This 9-month program tests whether combining yoga-based mindfulness with time-restricted eating improves cognition, physical fitness, metabolism, and plasma tau levels in adults 60–80 with subjective or mild cognitive impairment and positive pTau217.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 80 Years |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | St. Anne's University Hospital Brno, Czech Republic Academic / other |
| Locations | 1 site (Brno) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | June 27, 2025 |
| Trial ID | NCT07042087 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 60–80 with subjective cognitive impairment or mild cognitive impairment, MMSE 24–30, positive plasma pTau217, able to commit to a 9-month program and stable on any cholinesterase inhibitor therapy if applicable.
✕Probably not a fit
People with recent stroke or myocardial infarction, unstable or decompensated major medical conditions, active cancer within 5 years, significant neurological or sensory/motor impairments, long-term uncontrolled psychiatric illness, substance abuse, poor anticipated compliance, or unstable dementia medications are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized two-arm, 9-month intervention comparing mindfulness yoga plus time-restricted eating and nutritional counseling against cognitive training plus stretching in older adults at increased risk for Alzheimer disease. Primary and secondary outcomes include cognitive performance, plasma pTau217 as a marker of neurodegeneration, measures of physical fitness, and metabolic health. The protocol is harmonized with a parallel LIBRA-NET study at Slovak sites so that data from the cognitive-training/stretching arm and some clinical parameters are pooled for joint analysis. The combined approach tests whether lifestyle changes can modify both clinical and biomarker indicators of early neurodegeneration.
Why it matters
Potential benefit: If successful, this could offer a non-drug lifestyle approach to slow cognitive decline and reduce blood markers of neurodegeneration in at-risk older adults.
How similar studies have gone: Individual components—mindfulness/yoga, cognitive training, and time-restricted eating—have shown some cognitive or metabolic benefits in prior studies, but combining these interventions and measuring effects on plasma pTau217 is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 60-80 years * Diagnosis of Subjective Cognitive Impairment (SCI) or Mild Cognitive Impairment (MCI) * mini-mental-scale (MMSE) score between 24-30 * Positive plasma pTau217 biomarker * Stable dose of iAChE therapy (if applicable) * Ability to participate in a 9-month intervention Exclusion Criteria: * Stroke or myocardial infarction within the past year * Decompensated internal conditions (e.g., severe heart failure, kidney failure, unstable diabetes, GLP1 agonist therapy) * Long-term psychiatric treatment (except well-managed depression) * Neurological conditions affecting mobility or cognition (e.g., Parkinson's disease, severe tremor, epilepsy) * Severe sensory or motor impairment preventing protocol participation * Active cancer treated within the past 5 years * Poor anticipated compliance (e.g., transport issues, time constraints, non-cooperation) * Concurrent participation in another clinical study * Unstable iAChE medication regimen * Substance or alcohol dependence
Where it's running
-
Fnusa/ Icrc
Brno, Czechia Recruiting
Study contacts
- Principal investigator: Kateřina Sheardova, MD. PhD. — The International Clinical Research Center of St. Anne's University Hospital in Brno (FNUSA-ICRC)
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nutrition and exercise program for brain health in older adults
This study tests whether a 9-month program of exercise and nutrition can help improve brain health and physical function in older adults at risk for Alzheimer's disease.
-
Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease
A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.
-
Improving sleep and mindfulness for older adults in residential facilities
This study is testing a new program to help older adults in residential facilities improve their sleep and mindfulness to see if it makes them feel better overall.
-
A large-scale digital health study using Apple devices
This study is trying to see how data from Apple devices can help us understand and manage different health issues like mental health, sleep, and exercise for a wide range of people.
-
Hearing care to reduce neuropsychiatric symptoms in people with Alzheimer's and related dementias
This trial will try a tailored, community-delivered hearing care program using HEARS devices to see if it improves communication, reduces neuropsychiatric symptoms, and eases caregiver distress in English-speaking older adults with Alzheimer's disease or related dementias who have untreated hearing loss.
-
Collecting data on neurodegenerative diseases progression markers
This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.